EARLY BIRD DISCOUNT! Register by July 11, 2017 to receive 20% off your registration!
Or register 3 for the price of 2 with the coupon code rcdvb!
registration button


11th Neurodegenerative Conditions Research & Development

10th CNS Partnering & Deal-Making 


NeuroImaging Technologies in Drug Discovery


Advances in Neuroimmunology


GTCbio offers comprehensive sponsorship packages for all our meetings, including presentation opportunities, exhibit and booth space, as well as the event delegate list. All our packages can be customized to meet your company's budget. For information, please contact:

Amber Kempf
626-256-6405 x110
amber.kempf [at] gtcbio.com

GTCbio encourages attendees to showcase their research at the conference by presenting a poster. The top 2-3 submitted posters will also be selected to give short oral presentations as part of the meeting program. Abstracts will be accepted until July 11, 2017; slots fill up quickly so submit yours online ASAP!

Speakers | Agenda | Venue | Sponsors | Poster Submissions

Dear Colleague,

We are excited to announce the CNS Diseases World Summit, to be held on September 11-12, 2017 in Boston, MA. This meeting provides an interactive learning and relationship-building forum for all players in the CNS field. Colleagues from industry, academia, government agencies, and financing bodies will gather at the interface of research, partnerships, funding, and commercialization to find ways to move forward in a field that has been troubled with clinical failures.

The program will provide a comprehensive look at the current state of CNS, from research to commercialization. Above all, this event will provide networking opportunities in an intimate and accessible environment.

The CNS Diseases World Summit consists of four conferences:

11th Neurodegenerative Conditions Research & Development

9th CNS Partnering & Deal-Making


NeuroImaging Technologies for Drug Discovery


Advances in Neuroimmunology

A summit pass will get you access to all conferences. We invite you to join us as we connect, build relationships, and seek new ways forward into the future of CNS research and development.
We hope to see you there!

Best regards,

The 2017 Advisory Committee

2016 Advisory Board Members
Mark Allegretta, National Multiple Sclerosis Society
Gai Ayalon, Genetech
Robert Bell, Pfizer
Luca Benatti, EryDel
Adam Bristol, Aquilo Capital Management
Karen Chandross, Sanofi
Monica Coenraad, Rett Syndrome Research Trust
Frank Eeckman, Mavericks Capital
Lisa Ellerby, The Buck Institute
Howard Fillit, Alzheimer’s Drug Discovery Foundation
Daniel Grau, Sojournix
Marlene Haffner, Haffner Associates
Andreas Jeromin, NextGen Sciences Dx
Jeff Karan, Mavericks Capital
Robyn Klein, Washington University School of Medicine
David Michelson, Merck & Co.
John Renger, Merck & Co.
Susanna Rosi, University of California, San Francisco
Bavani Shankar, AstraZeneca
Jared Sterneckert, Technische Universität Dresden
Srinivasa Subramaniam, Scripps Research Institute
Gabriel Vargas, Amgen


Attend all GTCbio Conferences for one year for only $4,995 ($2,495 for academic and government).
Click here to sign up!

cns-diseases-world-summit Overview